{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:59:37Z","timestamp":1780441177232,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10067-024-07287-7","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T13:30:49Z","timestamp":1735047049000},"page":"831-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Frequency of severe infections in rheumatic disease patients receiving bDMARDs post-kidney transplantation: a multicenter study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-0591","authenticated-orcid":false,"given":"Tuba Demirci","family":"Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-2182","authenticated-orcid":false,"given":"Emel O\u011fuz","family":"K\u00f6ko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0298-4157","authenticated-orcid":false,"given":"Belk\u0131s Nihan","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2771-7725","authenticated-orcid":false,"given":"Derya","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-3972","authenticated-orcid":false,"given":"Enes","family":"Basaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-8179","authenticated-orcid":false,"given":"Abdurrahman Soner","family":"\u015eenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-8836","authenticated-orcid":false,"given":"Yavuz","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1206-4725","authenticated-orcid":false,"given":"Hamit","family":"K\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-4509","authenticated-orcid":false,"given":"Ayten","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-8648","authenticated-orcid":false,"given":"Timu\u00e7in","family":"Ka\u015fifo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-4180","authenticated-orcid":false,"given":"\u0130smail","family":"Sar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"7287_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1258\/RSMSMJ.54.2.9","volume":"54","author":"AJ Hill","year":"2009","unstructured":"Hill AJ, Thomson RJ, Hunter JA, Traynor JP (2009) The prevalence of chronic kidney disease in rheumatology outpatients. Scott Med J 54:9\u201312. https:\/\/doi.org\/10.1258\/RSMSMJ.54.2.9","journal-title":"Scott Med J"},{"key":"7287_CR2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMOA070265\/ASSET\/E4397CE0-A662-40F4-9B62-EF7BCC6FF6F1\/ASSETS\/IMAGES\/LARGE\/NEJMOA070265_T4.JPG","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJB, Gilbertson JA et al (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361\u20132371. https:\/\/doi.org\/10.1056\/NEJMOA070265\/ASSET\/E4397CE0-A662-40F4-9B62-EF7BCC6FF6F1\/ASSETS\/IMAGES\/LARGE\/NEJMOA070265_T4.JPG","journal-title":"N Engl J Med"},{"key":"7287_CR3","doi-asserted-by":"publisher","unstructured":"Chiu HY, Huang HL, Li CH et al (2015) Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications \u2013 a national population-based cohort study. PLoS One 10(9):e0136508. https:\/\/doi.org\/10.1371\/journal.pone.0136508","DOI":"10.1371\/journal.pone.0136508"},{"key":"7287_CR4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/S10067-019-04516-2\/FIGURES\/1","volume":"38","author":"R Ranza","year":"2019","unstructured":"Ranza R, de la Vega MC, Laurindo IMM et al (2019) Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR. Clin Rheumatol 38:2129\u20132139. https:\/\/doi.org\/10.1007\/S10067-019-04516-2\/FIGURES\/1","journal-title":"Clin Rheumatol"},{"key":"7287_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2054358118799692","volume":"5","author":"J Cowan","year":"2018","unstructured":"Cowan J, Bennett A, Fergusson N et al (2018) Incidence rate of post-kidney transplant infection: a retrospective cohort study examining infection rates at a large Canadian multicenter tertiary-care facility. Can J Kidney Heal Dis 5:1\u20138. https:\/\/doi.org\/10.1177\/2054358118799692","journal-title":"Can J Kidney Heal Dis"},{"key":"7287_CR6","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/J.TRANSPROCEED.2019.03.049","volume":"51","author":"DO Sendogan","year":"2019","unstructured":"Sendogan DO, Saritas H, Kumru G et al (2019) Outcomes of canakinumab treatment in recipients of kidney transplant with familial mediterranean fever: a case series. Transplant Proc 51:2292\u20132294. https:\/\/doi.org\/10.1016\/J.TRANSPROCEED.2019.03.049","journal-title":"Transplant Proc"},{"key":"7287_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/TRI.13312","volume":"31","author":"ZB \u00d6z\u00e7akar","year":"2018","unstructured":"\u00d6z\u00e7akar ZB, Keven K, \u00c7akar N, Yal\u00e7\u0131nkaya F (2018) Transplantation within the era of anti-IL-1 therapy: case series of five patients with familial Mediterranean fever-related amyloidosis. Transpl Int 31:1181\u20131184. https:\/\/doi.org\/10.1111\/TRI.13312","journal-title":"Transpl Int"},{"key":"7287_CR8","doi-asserted-by":"publisher","unstructured":"Trabulus S, Korkmaz M, Kaya E, Seyahi N (2018) Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever. Clin Transplant 32(8):e13345. https:\/\/doi.org\/10.1111\/ctr.13345","DOI":"10.1111\/ctr.13345"},{"key":"7287_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005108","author":"C Garrouste","year":"2016","unstructured":"Garrouste C, Anglicheau D, Kamar N et al (2016) Anti-TNFa therapy for chronic inflammatory disease in kidney transplant recipients. Clin Outcomes. https:\/\/doi.org\/10.1097\/MD.0000000000005108","journal-title":"Clin Outcomes"},{"key":"7287_CR10","doi-asserted-by":"publisher","unstructured":"Sommerer C, Schr\u00f6ter I, Gruneberg K et al (2022) Incidences of infectious events in a renal transplant cohort of the German Center of Infectious Diseases (DZIF). Open Forum Infect Dis 9(7):ofac243. https:\/\/doi.org\/10.1093\/ofid\/ofac243","DOI":"10.1093\/ofid\/ofac243"},{"key":"7287_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.46497\/ARCHRHEUMATOL.2021.8500","volume":"36","author":"V Yaz\u0131s\u0131z","year":"2021","unstructured":"Yaz\u0131s\u0131z V, Y\u0131lmaz VT, U\u00e7ar \u0130 et al (2021) The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients. Arch Rheumatol 36:366\u2013374. https:\/\/doi.org\/10.46497\/ARCHRHEUMATOL.2021.8500","journal-title":"Arch Rheumatol"},{"key":"7287_CR12","doi-asserted-by":"publisher","first-page":"E1913102","DOI":"10.1001\/JAMANETWORKOPEN.2019.13102","volume":"2","author":"J Bilal","year":"2019","unstructured":"Bilal J, Berlinberg A, Bin RI et al (2019) Risk of infections and cancer in patients with rheumatologic diseases receiving interleukin inhibitors: a systematic review and meta-analysis. JAMA Netw Open 2:E1913102. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2019.13102","journal-title":"JAMA Netw Open"},{"key":"7287_CR13","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/JAMA.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ et al (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275\u20132285. https:\/\/doi.org\/10.1001\/JAMA.295.19.2275","journal-title":"JAMA"},{"issue":"18","key":"7287_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41584-022-00755-x","volume":"184","author":"R Grainger","year":"2022","unstructured":"Grainger R, Kim AHJ, Conway R et al (2022) COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat Rev Rheumatol 184(18):191\u2013204. https:\/\/doi.org\/10.1038\/s41584-022-00755-x","journal-title":"Nat Rev Rheumatol"},{"key":"7287_CR15","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/ANNRHEUMDIS-2021-220418","volume":"80","author":"JA Sparks","year":"2021","unstructured":"Sparks JA, Wallace ZS, Seet AM et al (2021) Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry. Ann Rheum Dis 80:1137\u20131146. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2021-220418","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07287-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07287-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07287-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:31:22Z","timestamp":1738045882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07287-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7287"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07287-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the submitted work is their own and that copyright has not been breached in seeking its publication. They confirm that the article is an original work, has not been published before, and is not being considered for publication elsewhere in its final form, in either printed or electronic media.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 declaration"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}